Page last updated: 2024-08-21

reticulin and 2019 Novel Coronavirus Disease

reticulin has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akebo, H; Hatta, K; Kashihara, E; Manabe, A; Matsushita, S; Miyake, H; Okubo, G; Sada, RM; Tagawa, S; Yamada, M	1

Other Studies

1 other study(ies) available for reticulin and 2019 Novel Coronavirus Disease

Article	Year
TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:7 Topics: Adult; BNT162 Vaccine; Castleman Disease; COVID-19; COVID-19 Vaccines; Edema; Fever; Humans; Male; Primary Myelofibrosis; Reticulin; RNA, Messenger; Vaccination	2022

Article

Year

TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:7

Topics: Adult; BNT162 Vaccine; Castleman Disease; COVID-19; COVID-19 Vaccines; Edema; Fever; Humans; Male; Primary Myelofibrosis; Reticulin; RNA, Messenger; Vaccination

2022